{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:59:03Z","timestamp":1785135543599,"version":"3.55.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02246-9","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:53:05Z","timestamp":1782726785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal Metamorphosis: Deconstructing MPN Evolution with Single-Cell and Spatial Multi-Omics"],"prefix":"10.1007","volume":"26","author":[{"given":"Muhammad Shahid","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah K.","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Faiyaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zahid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah-Ud-Din","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya Devanathadesikan","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr Ali Mohamed","family":"Abdelgawwad El-Sehrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"22","key":"2246_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"J Spivak","year":"2017","unstructured":"Spivak J. Myeloproliferative neoplasms. N Engl J Med. 2017;376(22):2168\u201381.","journal-title":"N Engl J Med"},{"issue":"9464","key":"2246_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054\u201361.","journal-title":"Lancet"},{"key":"2246_CR3","unstructured":"Nangalia J et al. Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2. N Engl J Med. 2013. 369(25): pp. 2391\u2013405."},{"issue":"10","key":"2246_CR4","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","volume":"108","author":"AD Pardanani","year":"2006","unstructured":"Pardanani AD, et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood. 2006;108(10):3472\u20136.","journal-title":"Blood"},{"issue":"15","key":"2246_CR5","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","volume":"379","author":"J Grinfeld","year":"2018","unstructured":"Grinfeld J, et al. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med. 2018;379(15):1416\u201330.","journal-title":"N Engl J Med"},{"issue":"5","key":"2246_CR6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/bloodadvances.2020003444","volume":"5","author":"D Luque Paz","year":"2021","unstructured":"Luque Paz D, et al. Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood Adv. 2021;5(5):1442\u201351.","journal-title":"Blood Adv"},{"issue":"50","key":"2246_CR7","doi-asserted-by":"publisher","first-page":"E5401","DOI":"10.1073\/pnas.1407792111","volume":"111","author":"R Rampal","year":"2014","unstructured":"Rampal R, et al. Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms. Proc Natl Acad Sci U S A. 2014;111(50):E5401\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2246_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41375-022-01767-y","volume":"37","author":"J Mascarenhas","year":"2023","unstructured":"Mascarenhas J, et al. Biological drivers of clinical phenotype in myelofibrosis. Leukemia. 2023;37(2):255\u201364.","journal-title":"Leukemia"},{"issue":"7","key":"2246_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1412098","volume":"372","author":"CA Ortmann","year":"2015","unstructured":"Ortmann CA, et al. Effect of mutation order on myeloproliferative neoplasms. N Engl J Med. 2015;372(7):601\u201312.","journal-title":"N Engl J Med"},{"issue":"16","key":"2246_CR10","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1182\/blood.2022017697","volume":"141","author":"AR Moliterno","year":"2023","unstructured":"Moliterno AR, Kaizer H, Reeves BN. JAK2 V617F allele burden in polycythemia vera: burden of proof. Blood. 2023;141(16):1934\u201342.","journal-title":"Blood"},{"issue":"9","key":"2246_CR11","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s41588-023-01480-1","volume":"55","author":"A Rodriguez-Meira","year":"2023","unstructured":"Rodriguez-Meira A, et al. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution. Nat Genet. 2023;55(9):1531\u201341.","journal-title":"Nat Genet"},{"issue":"3","key":"2246_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.molcel.2020.04.008","volume":"78","author":"B Psaila","year":"2020","unstructured":"Psaila B, et al. Single-cell analyses reveal megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets. Mol Cell. 2020;78(3):477-492.e8.","journal-title":"Mol Cell"},{"issue":"2","key":"2246_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.hoc.2021.01.002","volume":"35","author":"D Royston","year":"2021","unstructured":"Royston D, Mead AJ, Psaila B. Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology. Hematol Oncol Clin North Am. 2021;35(2):279\u201393.","journal-title":"Hematol Oncol Clin North Am"},{"key":"2246_CR14","doi-asserted-by":"crossref","unstructured":"Peroni E, et al. Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology. Cell Commun Signal. 2024;22(1):510.","DOI":"10.1186\/s12964-024-01877-3"},{"issue":"2","key":"2246_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41375-024-02480-8","volume":"39","author":"RA Cooper","year":"2025","unstructured":"Cooper RA, et al. Spatial transcriptomic approaches for characterising the bone marrow landscape: pitfalls and potential. Leukemia. 2025;39(2):291\u20135.","journal-title":"Leukemia"},{"issue":"4","key":"2246_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1182\/blood.2021014668","volume":"141","author":"JM O\u2019Sullivan","year":"2023","unstructured":"O\u2019Sullivan JM, Mead AJ, Psaila B. Single-cell methods in myeloproliferative neoplasms: old questions, new technologies. Blood. 2023;141(4):380\u201390.","journal-title":"Blood"},{"issue":"3","key":"2246_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100125","volume":"1","author":"A Rodriguez-Meira","year":"2020","unstructured":"Rodriguez-Meira A, et al. TARGET-Seq: a protocol for high-sensitivity single-cell mutational analysis and parallel RNA sequencing. STAR Protoc. 2020;1(3):100125.","journal-title":"STAR Protoc"},{"issue":"7","key":"2246_CR18","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.ajpath.2017.03.009","volume":"187","author":"BB Guo","year":"2017","unstructured":"Guo BB, et al. Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations. Am J Pathol. 2017;187(7):1512\u201322.","journal-title":"Am J Pathol"},{"issue":"1","key":"2246_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41698-021-00144-9","volume":"5","author":"S Parenti","year":"2021","unstructured":"Parenti S, et al. Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis. npj Precision Oncol. 2021;5(1):4.","journal-title":"npj Precision Oncol"},{"issue":"1","key":"2246_CR20","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/s41467-021-21810-3","volume":"12","author":"B Demaree","year":"2021","unstructured":"Demaree B, et al. Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemia. Nat Commun. 2021;12(1):1583.","journal-title":"Nat Commun"},{"issue":"1","key":"2246_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3324\/haematol.2020.260448","volume":"106","author":"ER Thompson","year":"2021","unstructured":"Thompson ER, et al. Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing. Haematologica. 2021;106(1):313\u20135.","journal-title":"Haematologica"},{"issue":"6465","key":"2246_CR22","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366(6465):eaan4673.","journal-title":"Science"},{"issue":"7834","key":"2246_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","volume":"587","author":"LA Miles","year":"2020","unstructured":"Miles LA, et al. Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature. 2020;587(7834):477\u201382.","journal-title":"Nature"},{"issue":"4","key":"2246_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3324\/haematol.2024.285598","volume":"110","author":"S-H Jung","year":"2025","unstructured":"Jung S-H, et al. Different inflammatory, fibrotic, and immunological signatures between pre-fibrotic and overt primary myelofibrosis. Haematologica. 2025;110(4):938\u201351.","journal-title":"Haematologica"},{"issue":"1","key":"2246_CR25","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41467-022-30440-2","volume":"13","author":"N Itokawa","year":"2022","unstructured":"Itokawa N, et al. Epigenetic traits inscribed in chromatin accessibility in aged hematopoietic stem cells. Nat Commun. 2022;13(1):2691.","journal-title":"Nat Commun"},{"issue":"10","key":"2246_CR26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces MR, et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat Genet. 2016;48(10):1193\u2013203.","journal-title":"Nat Genet"},{"issue":"6","key":"2246_CR27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.stem.2016.10.019","volume":"19","author":"M Farlik","year":"2016","unstructured":"Farlik M, et al. DNA methylation dynamics of human hematopoietic stem cell differentiation. Cell Stem Cell. 2016;19(6):808\u201322.","journal-title":"Cell Stem Cell"},{"issue":"6294","key":"2246_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aaf2403","volume":"353","author":"PL St\u00e5hl","year":"2016","unstructured":"St\u00e5hl PL, et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353(6294):78\u201382.","journal-title":"Science"},{"issue":"9","key":"2246_CR29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius M, et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14(9):865\u20138.","journal-title":"Nat Methods"},{"issue":"4","key":"2246_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","volume":"174","author":"Y Goltsev","year":"2018","unstructured":"Goltsev Y, et al. Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging. Cell. 2018;174(4):968\u2013e98115.","journal-title":"Cell"},{"issue":"4","key":"2246_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41375-023-01848-6","volume":"37","author":"J Fo\u00dfelteder","year":"2023","unstructured":"Fo\u00dfelteder J, et al. Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia. 2023;37(4):843\u201353.","journal-title":"Leukemia"},{"issue":"8014","key":"2246_CR32","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41586-024-07388-y","volume":"629","author":"F Izzo","year":"2024","unstructured":"Izzo F, et al. Mapping genotypes to chromatin accessibility profiles in single cells. Nature. 2024;629(8014):1149\u201357.","journal-title":"Nature"},{"issue":"10","key":"2246_CR33","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/ajh.27013","volume":"98","author":"L Calabresi","year":"2023","unstructured":"Calabresi L, et al. Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms. Am J Hematol. 2023;98(10):1520\u201331.","journal-title":"Am J Hematol"},{"key":"2246_CR34","doi-asserted-by":"crossref","unstructured":"Sandoval L et al. Characterization and Optimization of Multiomic Single-Cell Epigenomic Profiling. Genes (Basel), 2023. 14(6). pg 1-25.","DOI":"10.3390\/genes14061245"},{"issue":"12","key":"2246_CR35","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1038\/s41375-024-02425-1","volume":"38","author":"W Walter","year":"2024","unstructured":"Walter W, et al. Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase. Leukemia. 2024;38(12):2644\u201352.","journal-title":"Leukemia"},{"issue":"7_Supplement","key":"2246_CR36","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/1538-7445.AM2023-806","volume":"83","author":"M Binder","year":"2023","unstructured":"Binder M, et al. Abstract 806: enhancer deregulation in TET2-mutant clonal hematopoiesis is associated with increased COVID-19 severity and mortality. Cancer Res. 2023;83(7_Supplement):806\u2013806.","journal-title":"Cancer Res"},{"issue":"5","key":"2246_CR37","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.stem.2023.04.012","volume":"30","author":"S Turkalj","year":"2023","unstructured":"Turkalj S, et al. GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells. Cell Stem Cell. 2023;30(5):722-740.e11.","journal-title":"Cell Stem Cell"},{"key":"2246_CR38","unstructured":"Myers RM et al. Integrated Single-Cell Genotyping and Chromatin Accessibility Charts\u2009<\u2009em>JAK2> Human Hematopoietic Differentiation. 2022: p. 2022.05.11.491515."},{"issue":"2","key":"2246_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.hoc.2021.01.001","volume":"35","author":"A Dunbar","year":"2021","unstructured":"Dunbar A, Park Y, Levine R. Epigenetic dysregulation of myeloproliferative neoplasms. Hematol Oncol Clin North Am. 2021;35(2):237\u201351.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"2246_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41556-019-0439-6","volume":"22","author":"C Baccin","year":"2020","unstructured":"Baccin C, et al. Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization. Nat Cell Biol. 2020;22(1):38\u201348.","journal-title":"Nat Cell Biol"},{"key":"2246_CR41","doi-asserted-by":"publisher","first-page":"106873","DOI":"10.1016\/j.compbiomed.2023.106873","volume":"159","author":"M Zhu","year":"2023","unstructured":"Zhu M, et al. MLSpatial: A machine-learning method to reconstruct the spatial distribution of cells from scRNA-seq by extracting spatial features. Comput Biol Med. 2023;159:106873.","journal-title":"Comput Biol Med"},{"issue":"8","key":"2246_CR42","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1038\/s41596-021-00556-8","volume":"16","author":"S Black","year":"2021","unstructured":"Black S, et al. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat Protoc. 2021;16(8):3802\u201335.","journal-title":"Nat Protoc"},{"key":"2246_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030320","author":"L Brunetti","year":"2017","unstructured":"Brunetti L, Gundry MC, Goodell MA. DNMT3A in leukemia. Cold Spring Harb Perspect Med. 2017. pg 1-18.\u00a0https:\/\/doi.org\/10.1101\/cshperspect.a030320.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2246_CR44","unstructured":"Jaiswal S et al. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes. N Engl J Med 371(26): pp. 2488\u201398."},{"issue":"7488","key":"2246_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush LI, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506(7488):328\u201333.","journal-title":"Nature"},{"issue":"1","key":"2246_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9\u201316.","journal-title":"Blood"},{"issue":"11","key":"2246_CR47","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ng.2413","volume":"44","author":"L Busque","year":"2012","unstructured":"Busque L, et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nature Genetics. 2012;44(11):1179\u201381.","journal-title":"Nature Genetics"},{"key":"2246_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1286491","volume":"14","author":"Z Peng","year":"2023","unstructured":"Peng Z, et al. Investigating the shared genetic architecture between hypothyroidism and rheumatoid arthritis. Front Immunol. 2023;14:1286491.","journal-title":"Front Immunol"},{"issue":"1","key":"2246_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.03.025","volume":"23","author":"M Jeong","year":"2018","unstructured":"Jeong M, et al. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells\u2009<\u2009em\u2009>\u2009In Vivo. Cell Rep. 2018;23(1):1\u201310.","journal-title":"Cell Rep"},{"issue":"2","key":"2246_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100744","volume":"5","author":"G Poon","year":"2025","unstructured":"Poon G, et al. Single-cell DNA sequencing reveals pervasive positive selection throughout preleukemic evolution. Cell Genomics. 2025;5(2):100744.","journal-title":"Cell Genomics"},{"issue":"6","key":"2246_CR51","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.molcel.2019.01.009","volume":"73","author":"A Rodriguez-Meira","year":"2019","unstructured":"Rodriguez-Meira A, et al. Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing. Mol Cell. 2019;73(6):1292-1305.e8.","journal-title":"Mol Cell"},{"issue":"1","key":"2246_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19119-8","volume":"11","author":"K Morita","year":"2020","unstructured":"Morita K, et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nature Communications. 2020;11(1):5327.","journal-title":"Nature Communications"},{"issue":"9","key":"2246_CR53","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1182\/bloodadvances.2021005867","volume":"6","author":"N Maslah","year":"2022","unstructured":"Maslah N, et al. Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition. Blood Advances. 2022;6(9):2813\u201323.","journal-title":"Blood Advances"},{"issue":"1","key":"2246_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13892-x","volume":"11","author":"E Mylonas","year":"2020","unstructured":"Mylonas E, et al. Single-cell analysis based dissection of clonality in myelofibrosis. Nat Commun. 2020;11(1):73.","journal-title":"Nat Commun"},{"issue":"8","key":"2246_CR55","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/ajh.27375","volume":"99","author":"A Tefferi","year":"2024","unstructured":"Tefferi A, Pardanani A, Gangat N. Treatment-associated decline in JAK2V617F allele burden in polycythemia vera: what does it mean? Am J Hematol. 2024;99(8):1459\u201361.","journal-title":"Am J Hematol"},{"issue":"1","key":"2246_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60884-1","volume":"16","author":"N Maslah","year":"2025","unstructured":"Maslah N, et al. JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms. Nat Commun. 2025;16(1):6270.","journal-title":"Nat Commun"},{"issue":"6746","key":"2246_CR57","doi-asserted-by":"publisher","first-page":"eado4188","DOI":"10.1126\/science.ado4188","volume":"388","author":"H Lin","year":"2025","unstructured":"Lin H, et al. Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis. Science. 2025;388(6746):eado4188.","journal-title":"Science"},{"issue":"4","key":"2246_CR58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMc0910063","volume":"362","author":"A Green","year":"2010","unstructured":"Green A, Beer P. Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med. 2010;362(4):369\u201370.","journal-title":"N Engl J Med"},{"issue":"3","key":"2246_CR59","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41375-019-0603-9","volume":"34","author":"FPS Santos","year":"2020","unstructured":"Santos FPS, et al. Prognostic impact of RAS-pathway mutations in patients with myelofibrosis. Leukemia. 2020;34(3):799\u2013810.","journal-title":"Leukemia"},{"key":"2246_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3324\/haematol.2013.091454","volume":"99","author":"M Brecqueville","year":"2013","unstructured":"Brecqueville M, et al. Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase. Haematologica. 2013;99:37\u201345.","journal-title":"Haematologica"},{"issue":"1","key":"2246_CR61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.2019000943","volume":"136","author":"AJ Dunbar","year":"2020","unstructured":"Dunbar AJ, Rampal RK, Levine R. Leukemia secondary to myeloproliferative neoplasms. Blood. 2020;136(1):61\u201370.","journal-title":"Blood"},{"issue":"6","key":"2246_CR62","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265-1281.e24.","journal-title":"Cell"},{"issue":"10","key":"2246_CR63","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1016\/j.apsb.2024.07.004","volume":"14","author":"Y Bao","year":"2024","unstructured":"Bao Y, et al. Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway. Acta Pharm Sin B. 2024;14(10):4461\u201377.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2246_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55231-9","volume":"15","author":"D Forte","year":"2024","unstructured":"Forte D, et al. Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia. Nat Commun. 2024;15(1):10878.","journal-title":"Nat Commun"},{"key":"2246_CR65","doi-asserted-by":"crossref","unstructured":"Pereira-Martins DA, et al. High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability. Signal Transduct Target Ther. 2025;10(1):222.","DOI":"10.1038\/s41392-025-02303-x"},{"issue":"4","key":"2246_CR66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12185-024-03789-x","volume":"120","author":"X Shi","year":"2024","unstructured":"Shi X, Feng M, Nakada D. Metabolic dependencies of acute myeloid leukemia stem cells. Int J Hematol. 2024;120(4):427\u201338.","journal-title":"Int J Hematol"},{"issue":"768","key":"2246_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj7552","volume":"16","author":"R Li","year":"2024","unstructured":"Li R, et al. A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis. Sci Transl Med. 2024;16(768):eadj7552.","journal-title":"Sci Transl Med"},{"key":"2246_CR68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154092","author":"JC Yao","year":"2022","unstructured":"Yao JC, et al. TGF-\u03b2 signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche. J Clin Invest. 2022. pg 1-20.\u00a0https:\/\/doi.org\/10.1172\/JCI154092.","journal-title":"J Clin Invest"},{"issue":"1","key":"2246_CR69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41375-024-02453-x","volume":"39","author":"IL Boueya","year":"2025","unstructured":"Boueya IL, et al. Endothelial heterogeneity in bone marrow: insights across development, adult life and leukemia. Leukemia. 2025;39(1):8\u201324.","journal-title":"Leukemia"},{"issue":"Supplement 1","key":"2246_CR70","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1182\/blood-2024-210924","volume":"144","author":"J Castorena","year":"2024","unstructured":"Castorena J, et al. Spatial Transcriptomic Profiling of Bone Marrow Vascular Niches Unveils an Endothelial Stress Signature in Myeloproliferative Neoplasms. Blood. 2024;144(Supplement 1):4516\u20134516.","journal-title":"Blood"},{"issue":"7","key":"2246_CR71","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3324\/haematol.2017.185736","volume":"103","author":"CHS Lin","year":"2018","unstructured":"Lin CHS, et al. JAK2V617F-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury. Haematologica. 2018;103(7):1160\u20138.","journal-title":"Haematologica"},{"issue":"15","key":"2246_CR72","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1111\/bph.70032","volume":"182","author":"L Lin","year":"2025","unstructured":"Lin L, et al. Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells. Br J Pharmacol. 2025;182(15):3476\u2013502.","journal-title":"Br J Pharmacol"},{"key":"2246_CR73","doi-asserted-by":"crossref","unstructured":"Caprioli C et al. Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities. 2022. Volume 11\u20132021.","DOI":"10.3389\/fonc.2021.796477"},{"key":"2246_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7729","author":"A Prestipino","year":"2018","unstructured":"Prestipino A, et al. Oncogenic JAK2(V617F) causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Sci Transl Med. 2018. pg 1-18.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.aam7729.","journal-title":"Sci Transl Med"},{"key":"2246_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136422","volume":"26","author":"X Li","year":"2025","unstructured":"Li X, Xu M, Wang Y. Monocyte involvement in the pathogenesis of myeloproliferative neoplasms. Int J Mol Sci. 2025;26:6422. https:\/\/doi.org\/10.3390\/ijms26136422.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2246_CR76","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1182\/blood.2019000051","volume":"134","author":"T Maekawa","year":"2019","unstructured":"Maekawa T, et al. Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab. Blood. 2019;134(10):814\u201325.","journal-title":"Blood"},{"issue":"6","key":"2246_CR77","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s12276-025-01465-6","volume":"57","author":"K Lv","year":"2025","unstructured":"Lv K, et al. Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation. Exp Mol Med. 2025;57(6):1202\u201315.","journal-title":"Exp Mol Med"},{"issue":"10","key":"2246_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101751","volume":"5","author":"K Liu","year":"2024","unstructured":"Liu K, et al. Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy. Cell Rep Med. 2024;5(10):101751.","journal-title":"Cell Rep Med"},{"key":"2246_CR79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-3-031-26163-3_15","volume":"1408","author":"S Kapor","year":"2023","unstructured":"Kapor S, et al. Increase in frequency of myeloid-derived suppressor cells in the bone marrow of myeloproliferative neoplasm: potential implications in myelofibrosis. Adv Exp Med Biol. 2023;1408:273\u201390.","journal-title":"Adv Exp Med Biol"},{"key":"2246_CR80","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.leukres.2016.02.004","volume":"43","author":"JC Wang","year":"2016","unstructured":"Wang JC, et al. Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm. Leuk Res. 2016;43:39\u201343.","journal-title":"Leuk Res"},{"key":"2246_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1381212","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, et al. Circulating immune cells and risk of osteosarcoma: a Mendelian randomization analysis. Front Immunol. 2024;15:1381212.","journal-title":"Front Immunol"},{"issue":"10","key":"2246_CR82","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/ajh.27428","volume":"99","author":"L Tavernari","year":"2024","unstructured":"Tavernari L, et al. Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts. Am J Hematol. 2024;99(10):1939\u201350.","journal-title":"Am J Hematol"},{"key":"2246_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-70861-x","author":"F Li","year":"2026","unstructured":"Li F, et al. Spatial heterogeneity of MDSCs mediated by ANXA1-FPRs signaling drives immune suppression in OSCC progression. Nat Commun. 2026. pg 1-22.\u00a0https:\/\/doi.org\/10.1038\/s41467-026-70861-x.","journal-title":"Nat Commun"},{"key":"2246_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113392","volume":"144","author":"DY Sun","year":"2025","unstructured":"Sun DY, et al. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies. Int Immunopharmacol. 2025;144:113392.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"2246_CR85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201541","volume":"218","author":"F Caiado","year":"2021","unstructured":"Caiado F, Pietras EM, Manz MG. Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med. 2021;218(7):e20201541.","journal-title":"J Exp Med"},{"issue":"3","key":"2246_CR86","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11899-019-00508-w","volume":"14","author":"LF Mendez Luque","year":"2019","unstructured":"Mendez Luque LF, et al. Key role of inflammation in myeloproliferative neoplasms: instigator of disease initiation, progression. and symptoms. Curr Hematol Malig Rep. 2019;14(3):145\u201353.","journal-title":"Curr Hematol Malig Rep"},{"key":"2246_CR87","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.exphem.2020.01.011","volume":"83","author":"EK Cook","year":"2020","unstructured":"Cook EK, Luo M, Rauh MJ. Clonal hematopoiesis and inflammation: partners in leukemogenesis and comorbidity. Exp Hematol. 2020;83:85\u201394.","journal-title":"Exp Hematol"},{"issue":"8","key":"2246_CR88","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.molcel.2025.03.018","volume":"85","author":"L Guo","year":"2025","unstructured":"Guo L, et al. Structural basis and biased signaling of proton sensation by GPCRs mediated by extracellular histidine rearrangement. Mol Cell. 2025;85(8):1658-1673.e7.","journal-title":"Mol Cell"},{"issue":"23","key":"2246_CR89","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1182\/bloodadvances.2021005491","volume":"5","author":"G Hobbs","year":"2021","unstructured":"Hobbs G, et al. PD-1 inhibition in advanced myeloproliferative neoplasms. Blood Adv. 2021;5(23):5086\u201397.","journal-title":"Blood Adv"},{"issue":"1","key":"2246_CR90","doi-asserted-by":"publisher","first-page":"20002","DOI":"10.1038\/s41598-022-16744-9","volume":"12","author":"B Liu","year":"2022","unstructured":"Liu B, et al. Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score). Sci Rep. 2022;12(1):20002.","journal-title":"Sci Rep"},{"issue":"4","key":"2246_CR91","doi-asserted-by":"publisher","first-page":"110412","DOI":"10.1016\/j.ygeno.2022.110412","volume":"114","author":"P Cheng","year":"2022","unstructured":"Cheng P, et al. Systematic investigation of the prognostic impact of clonal status of somatic mutations across multiple cancer types. Genomics. 2022;114(4):110412.","journal-title":"Genomics"},{"issue":"1","key":"2246_CR92","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41559-021-01586-x","volume":"6","author":"X Fu","year":"2022","unstructured":"Fu X, et al. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study. Nat Ecol Evol. 2022;6(1):88\u2013102.","journal-title":"Nat Ecol Evol"},{"issue":"7633","key":"2246_CR93","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540(7633):433\u20137.","journal-title":"Nature"},{"key":"2246_CR94","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025030094","author":"JJF Medeiros","year":"2026","unstructured":"Medeiros JJF, et al. A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis. Blood. 2026.\u00a0147 (19): 2238\u20132251.\u00a0https:\/\/doi.org\/10.1182\/blood.2025030094.","journal-title":"Blood"},{"key":"2246_CR95","doi-asserted-by":"publisher","first-page":"1252258","DOI":"10.3389\/fimmu.2024.1252258","volume":"15","author":"N \u00c1lvarez","year":"2024","unstructured":"\u00c1lvarez N, et al. Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges. Front Immunol. 2024;15:1252258.","journal-title":"Front Immunol"},{"issue":"5","key":"2246_CR96","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3892\/ol.2024.14681","volume":"28","author":"Q Ge","year":"2024","unstructured":"Ge Q, et al. Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review). Oncol Lett. 2024;28(5):548.","journal-title":"Oncol Lett"},{"issue":"4","key":"2246_CR97","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/bjh.70077","volume":"207","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia. Br J Haematol. 2025;207(4):1309\u201322.","journal-title":"Br J Haematol"},{"issue":"11","key":"2246_CR98","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s11427-024-2666-8","volume":"67","author":"X Mo","year":"2024","unstructured":"Mo X, et al. Single-cell immune landscape of measurable residual disease in acute myeloid leukemia. Sci China Life Sci. 2024;67(11):2309\u201322.","journal-title":"Sci China Life Sci"},{"issue":"3","key":"2246_CR99","first-page":"843","volume":"111","author":"T Murphy","year":"2026","unstructured":"Murphy T, et al. Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia. Haematologica. 2026;111(3):843\u201351.","journal-title":"Haematologica"},{"issue":"5","key":"2246_CR100","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41375-023-01886-0","volume":"37","author":"N Maslah","year":"2023","unstructured":"Maslah N, et al. Clonal architecture evolution in myeloproliferative neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape. Leukemia. 2023;37(5):957\u201363.","journal-title":"Leukemia"},{"issue":"18","key":"2246_CR101","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1158\/1078-0432.CCR-23-0276","volume":"29","author":"J Mascarenhas","year":"2023","unstructured":"Mascarenhas J, et al. A phase Ib trial of AVID200, a TGF\u03b2 1\/3 trap, in patients with myelofibrosis. Clin Cancer Res. 2023;29(18):3622\u201332.","journal-title":"Clin Cancer Res"},{"issue":"S1","key":"2246_CR102","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.5045\/br.2023.2023012","volume":"58","author":"SE Lee","year":"2023","unstructured":"Lee SE. Novel therapeutics for myelofibrosis. Blood Res. 2023;58(S1):S13-s19.","journal-title":"Blood Res"},{"key":"2246_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189111","volume":"26","author":"D Mart\u00ednez Anaya","year":"2025","unstructured":"Mart\u00ednez Anaya D, et al. The mechanisms of resistance to JAK inhibitors in lymphoid leukemias: a scoping review of evidence from preclinical models and case reports. Int J Mol Sci. 2025;26:9111. https:\/\/doi.org\/10.3390\/ijms26189111.","journal-title":"Int J Mol Sci"},{"key":"2246_CR104","doi-asserted-by":"crossref","unstructured":"Rinella SP et al. Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression. bioRxiv, 2024.","DOI":"10.1101\/2023.06.07.544058"},{"issue":"12","key":"2246_CR105","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.exphem.2016.08.007","volume":"44","author":"I Ceglia","year":"2016","unstructured":"Ceglia I, et al. Preclinical rationale for TGF-\u03b2 inhibition as a therapeutic target for the treatment of myelofibrosis. Exp Hematol. 2016;44(12):1138-1155.e4.","journal-title":"Exp Hematol"},{"issue":"2","key":"2246_CR106","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4143\/crt.2022.1026","volume":"55","author":"H Kim","year":"2023","unstructured":"Kim H, Park KU. Clinical circulating tumor DNA testing for precision oncology. Cancer Res Treat. 2023;55(2):351\u201366.","journal-title":"Cancer Res Treat"},{"issue":"7","key":"2246_CR107","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/his.15168","volume":"84","author":"E Williams","year":"2024","unstructured":"Williams E, et al. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results. Histopathology. 2024;84(7):1224\u201337.","journal-title":"Histopathology"},{"key":"2246_CR108","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/s41591-025-03716-5","volume":"31","author":"N Furer","year":"2025","unstructured":"Furer N, et al. A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnostics. Nat Med. 2025;31:2442\u201351.","journal-title":"Nat Med"},{"key":"2246_CR109","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.28.26344873","author":"R Gunaratne","year":"2026","unstructured":"Gunaratne R, et al. Personalized circulating tumor DNA (ctDNA) profiling enables superior and universal measurable residual disease (MRD) detection in acute myeloid leukemia (AML). medRxiv. 2026. https:\/\/doi.org\/10.64898\/2026.01.28.26344873.","journal-title":"medRxiv"},{"issue":"4","key":"2246_CR110","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3324\/haematol.2023.283950","volume":"110","author":"AA Patel","year":"2025","unstructured":"Patel AA, Rampal RK. Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia. Haematologica. 2025;110(4):828\u201339.","journal-title":"Haematologica"},{"issue":"16","key":"2246_CR111","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1182\/blood.2024024220","volume":"144","author":"DM Ross","year":"2024","unstructured":"Ross DM, Lane SW, Harrison CN. Identifying disease-modifying potential in myelofibrosis clinical trials. Blood. 2024;144(16):1679\u201388.","journal-title":"Blood"},{"key":"2246_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2025.100443","volume":"10","author":"E Holjak","year":"2025","unstructured":"Holjak E, et al. Circulating tumor DNA as part of the routine work-up for patients with suspected advanced lung cancer. J Liquid Biopsy. 2025;10:100443.","journal-title":"J Liquid Biopsy"},{"issue":"3","key":"2246_CR113","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bpsgos.2022.03.013","volume":"3","author":"A Antunes","year":"2023","unstructured":"Antunes A, Martins-de-Souza D. Single-cell RNA sequencing and its applications in the study of psychiatric disorders. Biol Psychiatry Glob Open Sci. 2023;3(3):329\u201339.","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"2246_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2025.100301","volume":"8","author":"N Fusco","year":"2025","unstructured":"Fusco N, et al. International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors. J Liquid Biopsy. 2025;8:100301.","journal-title":"J Liquid Biopsy"},{"issue":"3","key":"2246_CR115","doi-asserted-by":"publisher","first-page":"158","DOI":"10.52601\/bpr.2022.210041","volume":"8","author":"J He","year":"2022","unstructured":"He J, Lin L, Chen J. Practical bioinformatics pipelines for single-cell RNA-seq data analysis. Biophys Rep. 2022;8(3):158\u201369.","journal-title":"Biophys Rep"},{"issue":"1","key":"2246_CR116","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-021-01336-8","volume":"19","author":"MD Luecken","year":"2022","unstructured":"Luecken MD, et al. Benchmarking atlas-level data integration in single-cell genomics. Nat Methods. 2022;19(1):41\u201350.","journal-title":"Nat Methods"},{"key":"2246_CR117","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf723","author":"AM Nesari","year":"2026","unstructured":"Nesari AM, MotieGhader H, Ghorbian S. Advances and challenges in single-cell RNA sequencing data analysis: a comprehensive review. Brief Bioinform. 2026. pg 1-15.\u00a0https:\/\/doi.org\/10.1093\/bib\/bbaf723.","journal-title":"Brief Bioinform"},{"issue":"1","key":"2246_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14976-9","volume":"11","author":"P Qiu","year":"2020","unstructured":"Qiu P. Embracing the dropouts in single-cell RNA-seq analysis. Nat Commun. 2020;11(1):1169.","journal-title":"Nat Commun"},{"key":"2246_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105697","volume":"146","author":"J Xu","year":"2022","unstructured":"Xu J, et al. Evaluating the performance of dropout imputation and clustering methods for single-cell RNA sequencing data. Comput Biol Med. 2022;146:105697.","journal-title":"Comput Biol Med"},{"issue":"6","key":"2246_CR120","first-page":"1269","volume":"110","author":"YJ Kim","year":"2025","unstructured":"Kim YJ, Takahashi K. Emerging technologies of single-cell multi-omics. Haematologica. 2025;110(6):1269\u201377.","journal-title":"Haematologica"},{"key":"2246_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00817","volume":"8","author":"B He","year":"2020","unstructured":"He B, et al. Assessing the impact of data preprocessing on analyzing next generation sequencing data. Front Bioeng Biotechnol. 2020;8:817.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"2246_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-025-11235-3","volume":"26","author":"HJ Lim","year":"2025","unstructured":"Lim HJ, et al. A practical guide for choosing an optimal spatial transcriptomics technology from seven major commercially available options. BMC Genomics. 2025;26(1):47.","journal-title":"BMC Genomics"},{"issue":"1","key":"2246_CR123","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1038\/s41467-025-63414-1","volume":"16","author":"N Ozirmak Lermi","year":"2025","unstructured":"Ozirmak Lermi N, et al. Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples. Nat Commun. 2025;16(1):8499.","journal-title":"Nat Commun"},{"issue":"8","key":"2246_CR124","doi-asserted-by":"publisher","first-page":"btaf442","DOI":"10.1093\/bioinformatics\/btaf442","volume":"41","author":"EA Wynn","year":"2025","unstructured":"Wynn EA, et al. Simulating paired and longitudinal single-cell RNA sequencing data with rescueSim. Bioinformatics. 2025;41(8):btaf442.","journal-title":"Bioinformatics"},{"issue":"11","key":"2246_CR125","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1038\/s41592-025-02856-3","volume":"22","author":"C Liu","year":"2025","unstructured":"Liu C, et al. Multitask benchmarking of single-cell multimodal omics integration methods. Nat Methods. 2025;22(11):2449\u201360.","journal-title":"Nat Methods"},{"issue":"22","key":"2246_CR126","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf1270","volume":"53","author":"X Luo","year":"2025","unstructured":"Luo X, et al. CelLink: integrating single-cell multi-omics data with weak feature linkage and imbalanced cell populations. Nucleic Acids Res. 2025;53(22):gkaf1270.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2246_CR127","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1109\/TCBB.2022.3143770","volume":"19","author":"W Li","year":"2022","unstructured":"Li W, et al. Inferring latent microRNA-disease associations on a gene-mediated tripartite heterogeneous multiplexing network. IEEE ACM Trans Comput Biol Bioinform. 2022;19(6):3190\u2013201.","journal-title":"IEEE ACM Trans Comput Biol Bioinform"},{"key":"2246_CR128","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6782046","volume":"2020","author":"B He","year":"2020","unstructured":"He B, et al. Gene coexpression network and module analysis across 52 human tissues. BioMed Res Int. 2020;2020:6782046.","journal-title":"BioMed Res Int"},{"key":"2246_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2025.101178","author":"Y Imoto","year":"2025","unstructured":"Imoto Y. Comprehensive noise reduction in single-cell data with the RECODE platform. Cell Rep Methods. 2025. pg 1-18.\u00a0https:\/\/doi.org\/10.1016\/j.crmeth.2025.101178.","journal-title":"Cell Rep Methods"},{"issue":"11","key":"2246_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2025.101211","volume":"5","author":"J Niu","year":"2025","unstructured":"Niu J, Vasquez-Rios C, Ding J. Single-cell multiomics data integration and generation with scPairing. Cell Rep Methods. 2025;5(11):101211.","journal-title":"Cell Rep Methods"},{"issue":"1","key":"2246_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-026-03937-y","volume":"27","author":"S Cervilla","year":"2026","unstructured":"Cervilla S, et al. A technical comparison of spatial transcriptomics platforms across six cancer types. Genome Biol. 2026;27(1):22.","journal-title":"Genome Biol"},{"issue":"3","key":"2246_CR132","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ccell.2025.10.014","volume":"44","author":"M Rade","year":"2026","unstructured":"Rade M, et al. A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma. Cancer Cell. 2026;44(3):586-603.e9.","journal-title":"Cancer Cell"},{"key":"2246_CR133","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaf443","author":"T Zhang","year":"2025","unstructured":"Zhang T, et al. Multi-omics single-cell data alignment and integration with enhanced contrastive learning and differential attention mechanism. Bioinformatics. 2025. pg 1-22.\u00a0https:\/\/doi.org\/10.1093\/bioinformatics\/btaf443.","journal-title":"Bioinformatics"},{"issue":"10","key":"2246_CR134","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41592-025-02805-0","volume":"22","author":"D Lindenhofer","year":"2025","unstructured":"Lindenhofer D, et al. Functional phenotyping of genomic variants using joint multiomic single-cell DNA\u2013RNA sequencing. Nat Methods. 2025;22(10):2032\u201341.","journal-title":"Nat Methods"},{"issue":"8","key":"2246_CR135","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41592-024-02201-0","volume":"21","author":"H Cui","year":"2024","unstructured":"Cui H, et al. ScGPT: toward building a foundation model for single-cell multi-omics using generative AI. Nat Methods. 2024;21(8):1470\u201380.","journal-title":"Nat Methods"},{"issue":"1","key":"2246_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s44387-025-00064-0","volume":"2","author":"N Nouri","year":"2026","unstructured":"Nouri N, Artzi R, Savova V. An agentic AI framework for ingestion and standardization of single-cell RNA-seq data analysis. NPJ Artif Intell. 2026;2(1):8.","journal-title":"NPJ Artif Intell"},{"issue":"8","key":"2246_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2025.101326","volume":"6","author":"P Qiu","year":"2025","unstructured":"Qiu P, et al. BioLLM: A standardized framework for integrating and benchmarking single-cell foundation models. Patterns (N Y). 2025;6(8):101326.","journal-title":"Patterns (N Y)"},{"key":"2246_CR138","doi-asserted-by":"crossref","unstructured":"Sadilek A, et al. Privacy-first health research with federated learning. npj Digit Med. 2021;4(1):132.","DOI":"10.1038\/s41746-021-00489-2"},{"issue":"Supplement_1","key":"2246_CR139","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae090","volume":"25","author":"AM Veerappa","year":"2024","unstructured":"Veerappa AM, et al. CloudATAC: a cloud-based framework for ATAC-Seq data analysis. Brief Bioinform. 2024;25(Supplement_1):bbae090.","journal-title":"Brief Bioinform"}],"updated-by":[{"DOI":"10.1007\/s10238-026-02261-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000}}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02246-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:01:52Z","timestamp":1785132112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02246-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02246-9","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10238-026-02261-w","URL":"https:\/\/doi.org\/10.1007\/s10238-026-02261-w","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that Gen AI and large language model (LLM) were used in the creation of this manuscript. Generative AI items like instatext, wordvice, and DeepL were used for structural editing and improve handwriting of the text.","order":2,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper is submitted with the agreement of all its co-authors and the author list has been approved by all authors.","order":3,"name":"Ethics","label":"Author Agreement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"243"}}